MUC1 and cancer: The potential of thismodified glycopeptide as a mimic of a tumor-associated MUC1 antigentriggered us to test it in vivo, which proved that antibodies generatedin mice with this synthetic antigen recognized human cancer cell lineswith high selectivity.